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Summary
22q11 deletion (del22q11) syndrome is characterized
genetically by heterozygous deletions within chromo-
some 22q11 and clinically by a constellation of con-
genitalmalformationsof the aortic arch, heart, thymus,
and parathyroid glands described as DiGeorge syn-
drome (DGS).Here,we report that compoundheterozy-
gosity of mouse homologs of two 22q11 genes, CRKL
and TBX1, results in a striking increase in the pene-
trance and expressivity of a DGS-like phenotype com-
pared to heterozygosity at either locus. Furthermore,
we show that these two genes have critical dose-
dependent functions in pharyngeal segmentation, pat-
terning of the pharyngeal apparatus along the antero-
posterior axis, and local regulation of retinoic acid
(RA) metabolism and signaling. We can partially res-
cue one salient feature of DGS in Crkl+/2;Tbx1+/2 em-
bryos by genetically reducing the amount of RA pro-
duced in the embryo. Thus, we suggest that del22q11
is a contiguous gene syndrome involving dose-sensi-
tive interaction ofCRKL and TBX1 and locally aberrant
RA signaling.
Introduction
Abnormal development of a transient embryonic struc-
ture known as the pharyngeal apparatus has been
implicated in the pathogenesis of DGS (Larsen, 2001;
Lindsay, 2001). This structure, which arises during mid-
gestation, consists of reiterated pharyngeal arches sep-
arated medially by endodermal pouches and laterally by
ectodermal clefts. In humans and mice, there are five
pharyngeal arches (numbered 1–4 and 6) and four pha-
ryngeal pouches. Neural crest cells migrate from the
hindbrain into distinct pharyngeal arches and are
thought to convey positional information to the arches
from their rhombomere of origin (Trainor and Krumlauf,
2001). Segmentation of the arches, however, is depen-
*Correspondence: aimamoto@uchicago.edudent upon the pharyngeal endoderm, and the impor-
tance of interactions between these two tissues in pat-
terning the vertebrate head has become increasingly
clear (Piotrowski and Nusslein-Volhard, 2000). Experi-
mental disruption of numerous developmental path-
ways affecting either the neural crest or the pharyngeal
endoderm has been shown to recapitulate a DGS phe-
notype in model organisms.
Deletions on human chromosome 22 are the leading
cause of DGS in humans. Nearly 90% of del22q11 pa-
tients share a 3 Mb deletion at 22q11.2, while 8% harbor
a smaller 1.5 Mb deletion in the centromeric half of the 3
Mb region (reviewed by Lindsay, 2001; Scambler, 2000).
The remainder are characterized by smaller ‘‘atypical’’
deletions (reviewed by Lindsay, 2001; Scambler, 2000;
Yamagishi and Srivastava, 2003). An unsolved question
regarding 22q11 deletions is whether the associated
congenital defects are caused by loss of a single dose-
dependent 22q11 gene or rather by the combined loss of
multiple linked genes that may act in a common pathway
or in parallel during a critical period of pharyngeal devel-
opment. Evidence supporting the idea that multiple
22q11 genes may be dose dependent comes from pa-
tients with nonoverlapping deletions within the 3 Mb re-
gion that have been reported to have a similar spectrum
of defects (Baldini, 2002). Direct experimental evidence
from animal models that would support the hypothesis
that del22q11 is a contiguous gene syndrome, however,
has been lacking.
Mice homozygous for null alleles of the homologs of
either of two 22q11 genes, TBX1 or CRKL, each pheno-
copy multiple aspects of DGS (Guris et al., 2001; Jerome
and Papaioannou, 2001; Lindsay et al., 2001; Merscher
et al., 2001). The T box gene TBX1 is located within the
1.5 Mb deletion, whereas the adaptor-protein-encoding
gene CRKL, though it resides outside the 1.5 Mb dele-
tion, is located within the common 3 Mb deletion as
well as an atypical deletion on the distal half of 22q11
(Guris et al., 2001; Lindsay, 2001; Yamagishi and Srivas-
tava, 2003). Tbx1 has been identified as the dose-
dependent gene responsible for great vessel malforma-
tions that occur with partial penetrance in two chromo-
somal deletion models of del22q11 engineered in the
mouse, Df1 and Lgdel, and a small subset of Tbx1+/2
mice has been reported to develop mild malformations
of the great vessels (Jerome and Papaioannou, 2001;
Lindsay et al., 2001; Merscher et al., 2001). However,
these defects in Tbx1+/2 mice generally occur in the ab-
sence of malformations of the heart, thymus, or parathy-
roid glands (Jerome and Papaioannou, 2001; Merscher
et al., 2001), suggesting that haploinsufficiency of Tbx1
alone cannot account for the full spectrum of defects
seen in the majority of del22q11 patients (Merscher
et al., 2001; Scambler, 2000). Crkl is located outside
of the chromosome 16 region deleted in the Df1 and
Lgdel mutants (Guris et al., 2001; Lindsay et al., 1999;
Merscher et al., 2001; loci information obtained at
Mouse Genome Resources, www.ncbi.nlm.nih.gov/
genome/guide/mouse/). Although Crkl+/2 mice are gen-
erally normal, we have noted that in the C57BL/6
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craniofacial and thymic anomalies, signifying that in cer-
tain circumstancesCrkl is also dose sensitive (Figure S1;
see the Supplemental Data available with this article on-
line). Crkl is expressed ubiquitously and is highly abun-
dant in the pharyngeal region, neural tissues, and neural
crest derivatives (Guris et al., 2001), while Tbx1 is ex-
pressed in the pharyngeal endoderm, ectoderm, and
mesenchyme (Lindsay et al., 2001; Merscher et al.,
2001).
In general, the spectrum of defects seen in del22q11
patients with the common 3 Mb deletion or the smaller
deletions is the same; however, there is wide variability
in the severity and penetrance of characteristic defects
(from clinically silent to life threatening) even in patients
with identical deletions (Emanuel et al., 1999; Lindsay,
2001; Scambler, 2000). One hypothesis to explain this
variability is that genetic modifiers located outside
22q11 strongly affect phenotypic penetrance and ex-
pressivity. A few studies have identified modifiers that
enhance the phenotype of model organisms lacking
Tbx1 (Stalmans et al., 2003; Vitelli et al., 2002). In the ac-
companying manuscript (Moon et al., 2006), we show
that reduced dosage of one such modifier, Fgf8, enhan-
ces the heterozygous and homozygous phenotype of
Crkl mutants as well. These results suggest that com-
mon pathways may link multiple 22q11 genes during
critical stages of embryogenesis.
It is also known that either deficiency or excess vita-
min A and its biologically active derivative, retinoic
acid (RA), is detrimental to pharyngeal development
and causes a DGS phenotype in humans and rodents
(Mulder et al., 1998; Niederreither et al., 2003; Vermot
et al., 2003). Therefore, genes involved in RA metabolism
or signaling are candidate modifiers of the DGS pheno-
type associated with loss ofCrkl or Tbx1 in the mouse or
22q11 deletions in the human. To date, however, a direct
link between the RA signaling pathway and the patho-
genesis of DGS associated with 22q11 deletions has
not been experimentally demonstrated.
In this report, we show that compound heterozygosity
ofCrkl and Tbx1 in the mouse leads to a DGS phenotype
comprised of aortic arch, thymic, and parathyroid de-
fects with striking penetrance. We demonstrate that
these two genes play critical roles in pharyngeal seg-
mentation and patterning, and we show that RA sig-
naling is ectopically activated in embryos lacking Crkl
and/or Tbx1 in a dose-dependent manner. We deter-
mined that the gain of function in RA signaling correlates
with local changes in the expression of genes encoding
enzymes that synthesize and degrade RA in single and
compound mutant embryos. Furthermore, by geneti-
cally reducing the amount of RA produced in Crkl+/2;
Tbx1+/2 embryos, we show that the penetrance of
thymic defects, a salient feature of DGS, can be dra-
matically reduced. These results provide compelling
evidence to suggest that, in the majority of cases,
del22q11 is a contiguous gene syndrome in which
dose-sensitive interaction of CRKL and TBX1 plays a
major role. In addition, our findings suggest that local
loss of retinoid homeostasis and aberrant RA signaling
resulting from the reduced dosage of CRKL and TBX1
is a critical step in the pathogenesis of DGS associated
with 22q11 deletions.Results
Crkl and Tbx1 Genetically Interact
To test the hypothesis that Crkl and Tbx1 may interact
genetically during pharyngeal development, we gener-
ated Crkl+/2;Tbx1+/2 embryos with null alleles of both
genes in either the trans or cis configuration on mouse
chromosome 16. We found that compound heterozy-
gosity of both Crkl and Tbx1 in either configuration reca-
pitulates thymic, parathyroid, and cardiovascular de-
fects characteristic of DGS at a penetrance far greater
than that generated by heterozygosity of Crkl or Tbx1
alone. A total of 30 out of 35 Crkl+/2;Tbx1+/2 compound
heterozygotes examined by gross dissection at E16.5
and P2 exhibited thymic defects, including bilateral hy-
poplasia as well as unilateral ectopic or missing lobes
(Figures 1F and 1G; Table 1). Nearly 100% of these
same Crkl+/2;Tbx1+/2 compound heterozygotes (34
out of 35 examined) had abnormalities of the great ves-
sels, including interrupted aortic arch type B, interrup-
ted cervical aortic arch, interrupted right retro-esopha-
geal aortic arch, and aberrant emergence of the right
subclavian artery (Figures 1C–1E; Table 1). Most cases
of right subclavian artery anomalies involved distal
emergence of this artery from the right common carotid
artery. It is noteworthy that great vessel defects in 60%
of Crkl+/2;Tbx1+/2 embryos were bilateral. Consistent
with previous reports, 28% (5/18) of Tbx1+/2 embryos
had great vessel defects limited to either the right or
the left side, and in only one case was thymic hypoplasia
also observed (Figure 1B; Table 1). No abnormalities
were found in 21 wild-type or 15 Crkl+/2 heterozygotes.
(Figure 1A; Table 1). Approximately 25% of Crkl+/2;
Tbx1+/2 embryos evaluated by histological sections
also had ventricular septal defects accompanied by an
overriding aorta (Figures 1H and 1I), both components
of tetralogy of Fallot, a constellation of heart defects of-
ten associated with 22q11 deletions (Botto et al., 2003).
In addition, we observed parathyroid aplasia in 90% of
Crkl+/2;Tbx1+/2 embryos evaluated by histological sec-
tions (11/20 unilateral and 7/20 bilateral cases) (Figures
1J and 1K). Likewise, development of parathyroid pri-
mordia, assayed by expression of Gcm2 (Gordon
et al., 2001; Gunther et al., 2000) in the third pharyngeal
pouch at E10.5, was impaired in 13 out of 14 Crkl+/2;
Tbx1+/2 embryos (Figures 1L and 1M).
Consistent with the incidence of lethal defects ob-
served in Crkl+/2;Tbx1+/2 embryos, we found that re-
covery of postnatal cis-Crkl+/2;Tbx1+/2 pups from cis-
Crkl+/2;Tbx1+/2 3 C57BL/6 breeding pairs maintained
in our colony was significantly reduced compared to
the recovery of wild-type pups from the same breeder
parents (142 wild-type versus 97 cis-Crkl+/2;Tbx1+/2
pups recovered, p = 0.0036). Crkl2/2;Tbx12/2 embryos
generated by timed mating of cis-Crkl+/2;Tbx1+/2 ani-
mals were present at the expected Mendelian ratio at
E10.5; however, they die shortly thereafter (data not
shown).
Impaired Development of the Fourth Pharyngeal
Arch Artery in Crkl+/2;Tbx1+/2 Embryos
Aortic arch malformations in Crkl+/2;Tbx1+/2 compound
heterozygotes were traced to impaired development of
the fourth pharyngeal arch artery. The great vessels of
Dose-Dependent Interaction of Crkl and Tbx1
83Figure 1. Aortic Arch, Thymic, and Parathy-
roid Defects in Crkl+/2;Tbx1+/2 Compound
Heterozygotes
(A) Gross anatomy of the aortic arch and as-
sociated vessels in an E16.5 wild-type em-
bryo.
(B) Aberrant origin of the right subclavian ar-
tery in a Tbx1 heterozygote at E16.5.
(C–E) Crkl+/2;Tbx1+/2 embryos at E16.5 dis-
played fourth arch artery defects such as (C)
cervical aortic arch, (D) right retro-esopha-
geal aortic arch, (E) interrupted aortic arch
type B, and (C–E) aberrant origin of the right
subclavian artery. (C and E) The white arrows
show the origin of either the right subclavian
artery or the descending aorta. (D) The black
arrow shows the origin of a right-sided arch
connecting to the descending aorta behind
the esophagus.
(F and G) Thymus in (F) wild-type and (G)
Crkl+/2;Tbx1+/2 embryos at P2. Thymic lobes
in compound heterozygotes were bilaterally
hypoplastic compared to wild-type controls
and were often located ectopically behind
the vessels of the aortic arch in compound
heterozygotes.
(H and I) Histological sections of the heart in
a (H) wild-type and (I) Crkl+/2;Tbx1+/2 embryo
at E16.5. A ventricular septal defect (indi-
cated by the black arrow) accompanied by
an overriding aorta is present in the (I)Crkl+/2;
Tbx1+/2 embryo.
(J and K) The development of parathyroid
glands was assessed in histological sections
in (J) wild-type and (K) Crkl+/2;Tbx1+/2 em-
bryos. Parathyroid glands were unilaterally
or bilaterally absent in the majority of Crkl+/2;
Tbx1+/2 embryos.
(L and M) Expression of the parathyroid pri-
mordium markerGcm2 in the third pharyngeal pouch of (L) wild-type and (M) Crkl+/2;Tbx1+/2 embryos at E10.5. The inset shows an enlargement
of the third pharyngeal pouch.
Ab-RSA, aberrant origin of the right subclavian artery; ao, aorta; CAA, cervical aortic arch; da, descending aorta; es, esophagus; IAA-B, inter-
rupted aortic arch type B; pt, pulmonary trunk; RAA, right retro-esophageal aortic arch; ra and la, right or left atrium; rcc and lcc, right or left
common carotid artery; rsa and lsa, right or left subclavian artery; r-Th and l-Th, right or left thymic lobe; tr, trachea; vt, ventricle; es, esophagus;
tr, trachea; td, thyroid gland; p, parathyroid gland.the mature aortic arch begin as bilaterally symmetric ar-
teries that run through the pharyngeal arches connect-
ing the aortic sac to the dorsal aorta (Larsen, 2001). By
E10.5 in mice, arteries have formed in pharyngeal arches
3, 4, and 6 that will soon undergo a process of asymmet-
rical remodeling to give rise to the aortic arch seen in the
adult. The left fourth arch artery will form the arch of
aorta connecting the ventral and left dorsal aortas, while
the right fourth arch artery will form the proximal right
subclavian artery, and the third arch arteries will become
the left and right common carotid arteries. When exam-
ined between E10.5 and E11.0, wild-type and Crkl+/2
embryos had bilaterally formed the third, fourth, and
sixth arch arteries, whereas in most Crkl+/2;Tbx1+/2 em-
bryos the fourth arch artery was absent (Table 2; Fig-
ures S2A, S2B, S2E, and S2F). In the remaining Crkl+/2;
Tbx1+/2 embryos as well as most Tbx1 heterozygotes,
the fourth arch artery was hypoplastic (Table 2; Fig-
ures S2C and S2D) (Jerome and Papaioannou, 2001;
Morishima et al., 2003; Vitelli et al., 2002). The majority
of Tbx1+/2 embryos appear to recover from this early
defect and form a normal aortic arch (Jerome and Pa-
paioannou, 2001; Lindsay, 2001; Lindsay and Baldini,2001). The increased incidence and expressivity of
aortic arch malformations seen in older Crkl+/2;Tbx1+/2
mutants compared to Tbx1+/2 embryos correlates well
with the comparative penetrance and severity of fourth
arch artery defects observed in these embryos at
E10.5 (Tables 1 and 2). The incidence of bilateral defects
and arch artery aplasia is significantly greater in Crkl+/2;
Tbx1+/2 embryos at this stage. Remodeling of the arch
arteries is also abnormal in Crkl+/2;Tbx1+/2 embryos as-
sessed at E11.5 (Figures S2G and S2H).
Tbx1 and Crkl Each Play Dose-Dependent Roles
in Pharyngeal Segmentation
We hypothesized that the absence of the fourth pharyn-
geal arch artery in Crkl+/2;Tbx1+/2 embryos may be due
to impaired development of the fourth arch itself. Pax1
is a marker of the pharyngeal pouches that separate
the pharyngeal arches (Neubuser et al., 1995). Analysis
of Pax1 expression revealed four distinct pharyngeal
pouches separating five pharyngeal arches in wild-type
embryos at E10.5 (Figure 2A). In contrast, in stage-
matched Crkl+/2;Tbx1+/2 embryos, the fourth pouch
was absent or severely hypoplastic (Figure 2E),
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Abnormal/ Totala IAA-Bb RAAc CAA Ab-RSA HTd
Vessel and Thymic
Defectse
trans-Crkl+/2;Tbx1+/2 16f/16 1 1 6 16 14 (5) 14g
cis-Crkl+/2;Tbx1+/2 18f/19 2 6 (3) 2 18 14 (2) 14g
Tbx1+/2 6/18 0 0 1 4 2 1
Crkl+/2 0/15 0 0 0 0 0 0
Wild-type 0/21 0 0 0 0 0 0
a Animals between E16.5 and P2 were dissected to record morphological anomalies. Abnormal embryos were scored by the presence of either
great vessel or thymic defects. The number of cases with each anomaly is shown. IAA-B, interrupted aortic arch type B; RAA, retro-oesophageal
right aortic arch; CAA, cervical aortic arch; Ab-RSA, aberrant origin of right subclavian artery; HT, hypoplastic thymic lobes.
b IAA-B cases shown here exclude cases with RAA.
c RAA cases shown here are without a normal left-sided aortic arch; the number in parentheses indicates cases in which double aortic arch forms
a complete vascular ring. These three cases are in addition to the six cases of RAA.
d HT cases shown in parentheses are embryos with an ectopic thymic lobe. All cases of ectopic thymus were hypoplastic. One case each in trans-
and cis-Crkl+/2;Tbx1+/2 groups had a missing lobe (data not shown).
e The number of embryos that exhibit both great vessel and thymic malformations is shown.
f Significantly different from the Tbx1+/2 group (Fisher’s exact test, p < 0.00011).
g Significantly different from the Tbx1+/2 group (Fisher’s exact test, p < 0.00003).suggesting that the caudal two pharyngeal arches fuse
and that a distinct fourth arch fails to form in these em-
bryos. We found that in Tbx1+/2 embryos the fourth
pouch was hypoplastic (Figure 2B), whereas in Tbx12/2
mutants only the first pharyngeal pouch formed as previ-
ously reported (Figure 2C) (Jerome and Papaioannou,
2001). Although Crkl+/2 embryos appeared normal, the
formation of the fourth pouch was mildly impaired in
a subset of Crkl2/2 embryos (Figure 2D). In addition, in
approximately 15% of Crkl2/2 embryos recovered at
E10.5, fusion of the first and second pharyngeal arches
was observed (data not shown). All pharyngeal pouches
failed to form in embryos lacking both copies ofTbx1and
Crkl (Figure 2F), suggesting that both these genes play
critical, dose-dependent roles in pouch formation.
Altered Pharyngeal Patterning in Crkl;Tbx1 Mutants
In addition to the defects in caudal pharyngeal arch for-
mation, we found that regional patterning is disturbed in
the absence of Crkl and Tbx1. Spatial restriction of Hox
genes imparts positional identity along the anteroposte-
rior (AP) axis. While no differences were detected in the
expression of numerous Hox genes (including Hoxb1,
Hoxb3, Hoxb4, and Hoxd4) between single Crkl or
Tbx1 heterozygotes and wild-type embryos, ectopic an-
terior expression of these genes was consistently ob-served in the pharyngeal region of Crkl+/2;Tbx1+/2 as
well as Tbx1 single and Crkl2/2;Tbx12/2 embryos com-
pared to controls at E10.5. The ectopic anterior expres-
sion of these Hox genes suggests that pharyngeal tis-
sues are abnormally posteriorized in mutant embryos.
Interestingly, these patterning defects appear to be re-
stricted to the pharyngeal region, as marker expression
for all genes examined was normal in the hindbrain and
trunk of mutant embryos.
Expression of Hoxb1, which normally is restricted to
the endoderm and mesoderm caudal to pouch 4 in
wild-type embryos at E10.5, was adjacent to the third
pouch in Crkl+/2;Tbx1+/2 embryos (Figures 3A and 3B);
however, the size of the expression domain was un-
changed. In addition, ectopic anterior expression of
Hoxb1 was observed in the pharyngeal endoderm of
Tbx12/2 and Crkl2/2;Tbx12/2 embryos (Figure 3C). In
wild-type embryos,Hoxb3 is normally expressed in pha-
ryngeal pouches 3 and 4 and in the mesenchyme of pha-
ryngeal arches 3, 4, and 6. In Crkl+/2;Tbx1+/2 embryos,
this general pattern of expression is maintained; how-
ever, caudal streams of neural crest expressing Hoxb3
appear to fuse in the absence of a distinct fourth pharyn-
geal arch and there is a striking increase in Hoxb3 ex-
pression in the third pharyngeal pouch and the sur-
rounding mesenchyme (Figures 3D and 3E).Table 2. Incidence of Fourth Pharyngeal Arch Artery Defects in Crkl+/2;Tbx1+/2 Compound Heterozygous Embryos
Abnormal/Totala
Right Fourth PAA Left Fourth PAA
Bilateral Casesb
Cases with Absent
Fourth PAAcAbsent Hypoplastic Absent Hypoplastic
Crkl+/2;Tbx1+/2 25/25 20 4 14 9 22d (12e) 22d
Tbx1+/2 13/15 2 9 2 4 4 (1) 3
Crkl+/2 0/10 0 0 0 0 0 0
Wild-type 1/24 0 1 0 0 0 0
a Embryos were examined by intracardiac ink injection at E10.75–11.0. Abnormal embryos are scored by the presence of either hypoplastic or
absent fourth pharyngeal arch arteries (PAAs).
b The number of embryos with bilaterally abnormal (hypoplastic or absent) fourth PAAs. The numbers in parentheses indicate cases of bilaterally
missing fourth PAAs.
c The number of embryos with a missing fourth PAA on one or both sides.
d Significantly different from that of the Tbx1+/2 group (Fisher’s exact test, p < 0.00015).
e Significantly different from that of the Tbx1+/2 group (Fisher’s exact test, p = 0.0128).
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85Figure 2. Pharyngeal Pouch Development in
Wild-Type and Mutant Embryos
(A–F) Endodermal pouch formation was as-
sessed by expression of Pax1 detected by
in situ hybridization at E10.5 (w34–38 so-
mites). (A) Pharyngeal pouches 1–4 were
present bilaterally in 12 wild-type embryos.
(B) The fourth pharyngeal pouch was bilater-
ally hypoplastic in 7/8 Tbx1+/2 embryos. In
1/8 embryos, the fourth pouch was unilater-
ally absent (data not shown). (C) Only the first
pharyngeal pouch is formed in Tbx12/2 em-
bryos. (D) The fourth pharyngeal pouch was
hypoplastic in 6/6 Crkl2/2 embryos. In two
cases, this defect was bilateral, and, in four in-
stances, it was unilateral. (E) The fourth pha-
ryngeal pouch was absent in 16/16 Crkl+/2;
Tbx1+/2 compound heterozygotes. In 9/16
heterozygotes, the defect was bilateral,
whereas, in 7/16, the fourth pouch was absent
on one side and hypoplastic on the other. (F)
No pharyngeal pouches were present in 4/4
Crkl2/2;Tbx12/2 double homozygous em-
bryos, although the first arch forms and
Pax1expression is detected in the pharyngeal
endoderm. a, arch; p, pharyngeal pouch; s,
somite.In the hindbrain, expression of Hoxb4 and Hoxd4 be-
gins at the rhombomere 6/7 boundary. In the pharyngeal
region, we have noted thatHoxb4 andHoxd4 expression
appears restricted to the pharyngeal endoderm and
mesenchyme caudal to the fourth pharyngeal pouch
and is normally excluded from the fourth pharyngeal
arch in wild-type embryos at E10.5 (Figures 3F and 3I).
Ectopic expression of Hoxb4 and Hoxd4 in the mesen-
chyme and endoderm caudal to the third pouch was ob-
served in Crkl+/2;Tbx1+/2 embryos at E10.5 (Figures 3G
and 3J), although expression in the hindbrain was nor-
mal. This ectopic expression was expanded anteriorly
in the pharyngeal endoderm of Tbx12/2 and Crkl2/2;
Tbx12/2 embryos and was observed in neural crest mi-
grating adjacent to the rhombomere 6/7 boundary in
these mutants (Figures 3H and 3K). The functional signif-
icance of observed changes in Hox gene expression in
mutant embryos and whether such changes are primary
or secondary to defects in pharyngeal segmentation are
questions currently under investigation.
Locally Aberrant RA Signaling in Crkl
and Tbx1 Mutants
It has experimentally been shown that a gain of function
in RA signaling can lead to defects in pharyngeal seg-
mentation and a DGS phenotype in mice (Ross et al.,
2000; Vermot et al., 2003). Furthermore, Hoxb1, Hoxb3,
Hoxb4, and Hoxd4 are known transcriptional targets of
RA (Bel-Vialar et al., 2002; Folberg et al., 1999; Rossant
et al., 1991). Although their expression is not wholly de-
pendent on RA, RA is required for the normal expression
of these Hox genes, and exogenous RA treatment has
been shown to induce ectopic expression of these tar-
gets in the hindbrain (Hoxb1, Hoxb3, Hoxb4, and
Hoxd4) and the pharyngeal endoderm (Hoxb1) (Bel-Via-
lar et al., 2002; Folberg et al., 1999; Matt et al., 2003;
Wendling et al., 2000). Thus, the ectopic anterior expres-
sion of these RA target genes observed in the pharyn-
geal region of Crkl+/2;Tbx1+/2 as well as Tbx12/2 andCrkl2/2;Tbx12/2 embryos is consistent with the hypoth-
esis that RA signaling is ectopically activated in these
mutants.
To further explore this possibility, we examined the
expression of another known transcriptional target of
RA, Rarb, the gene encoding the RA receptor b. In
wild-type embryos at E10.5, expression of Rarb is re-
stricted in the pharyngeal region to the endoderm and
mesoderm caudal to the fourth pharyngeal arch and
a small site of expression in the epithelia between the
first and second arches (Figure 4A). In Crkl+/2;Tbx1+/2
embryos, expression of Rarb is enhanced between the
first and second arches and is found adjacent to the
third pharyngeal pouch in the pharyngeal endoderm
(Figure 4B). Dramatic anterior expansion of Rarb ex-
pression is observed in the pharyngeal endoderm of
Tbx12/2 and Crkl2/2;Tbx12/2 embryos (Figures 4C and
4D). In Crkl2/2;Tbx12/2 embryos, ectopic expression
was also observed in the maxillary and mandibular por-
tions of the first pharyngeal arch as well as the fronto-
nasal mass (Figure 4D). Similar changes in the expres-
sion of Rarb were observed in Tbx12/2 and Crkl2/2;
Tbx12/2 embryos at E9.5 (data not shown).
To further test the hypothesis that there is a local gain
of function in RA signaling in the absence of Crkl and
Tbx1, we introduced a RARE reporter transgene con-
sisting of a canonical RA response element followed
by the hsp68 promoter and the LacZ gene into mutant
and control embryos. The pattern of b-galactosidase ac-
tivity at a given stage assessed by incubating embryos
with a colorimetric substrate is thought to reflect the dis-
tribution of RA at that time (Rossant et al., 1991), thus al-
lowing us to qualitatively assess the levels and pattern of
RA in the pharyngeal region of mutant embryos. At
E10.5, ectopic reporter activity was observed in the
head mesoderm of Crkl2/2 embryos compared to wild-
type controls when the colorimetric reaction was al-
lowed to proceed overnight (Figures 4E and 4F). Similar
ectopic reporter activity was observed in the head
Developmental Cell
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Mutant Embryos
(A–C) Hoxb1 expression detected by RNA
in situ hybridization in (A) wild-type, (B)
Crkl+/2;Tbx1+/2, and (C) Crkl2/2;Tbx12/2 em-
bryos at E10.5.
(D and E) Hoxb3 expression detected by RNA
in situ hybridization in (D) wild-type and (E)
Crkl+/2;Tbx1+/2 embryos at E10.5.
(F–H) Hoxb4 expression detected by RNA in
situ hybridization in (F) wild-type, (G) Crkl+/2;
Tbx1+/2, and (H) Tbx12/2 embryos at E10.5.
Hoxb4 expression is expanded anteriorly in
the pharyngeal endoderm in Tbx12/2 em-
bryos ([H], indicated by the black arrow) and
is detected in the neural crest immediately
adjacent to rhombomere 7. Hoxb4 expres-
sion in Crkl2/2;Tbx12/2 double homozygous
mutants is identical to that of Tbx12/2 em-
bryos (data not shown).
(I–K) Hoxd4 expression detected by RNA in
situ hybridization in (I) wild-type, (J) Crkl+/2;
Tbx1+/2, and (K) Crkl2/2;Tbx12/2 embryos
at E10.5. Hoxd4 expression in Tbx12/2 em-
bryos (data not shown) is identical to that of
Crkl2/2;Tbx12/2 embryos. a, pharyngeal
arch; ov, otic vesicle; p, pharyngeal pouch.mesoderm of Tbx1 homozygous mutants as well as in
the pharyngeal endoderm of these embryos (Figure 4G).
This ectopic reporter activity was enhanced in stage-
matched Crkl2/2;Tbx12/2 embryos in these tissues at
this stage and was also observed in the hindbrain (Fig-
ure 4H). An abnormal pattern of RA distribution and sig-
naling was already apparent in Tbx12/2 and Tbx12/2;
Crkl2/2 embryos in the head mesoderm as well as ven-
tral pharyngeal tissues at E9.0 (Figures 4K and 4N).
While no significant differences in the pattern of reporter
activity were detected in Crkl+/2;Tbx1+/2 embryos com-
pared to single heterozygous embryos or wild-type un-
der these conditions at E10.5 (data not shown), subtle
differences in the anterior limit ofRARE reporter expres-
sion in the head mesoderm were detected between
Crkl+/2;Tbx1+/2 embryos compared to wild-type con-
trols at E9.0 (Figures 4L, 4M, and 4I). RARE reporter ex-
pression in Crkl2/2 embryos was comparable to wild-
type controls at E9.0 (Figures 4J and 4I).
Local Changes in the Expression of Genes Involved
in RA Metabolism in Crkl;Tbx1 Mutants
We hypothesized that the apparent local gain of function
in RA signaling observed in embryos lacking Crkl and/or
Tbx1 may be due to local defects in retinoid metabolismthat result in abnormally high levels of RA and/or an ab-
normal pattern of RA distribution in these mutants. In the
embryo, enzymes known as retinaldehyde dehydro-
genases (Raldh) catalyze a key step in the conversion
of retinol to RA (Ross et al., 2000). A class of cytochrome
P450 enzymes encoded by Cyp26 genes, in turn, catab-
olize RA (Abu-Abed et al., 2002; Sakai et al., 2004).Raldh
and Cyp26 genes are expressed in complementary pat-
terns during embryogenesis, and together their prod-
ucts act to ensure stereotypic levels of RA in specific tis-
sues and a reproducible pattern of RA signaling in the
developing embryo.
We first examined the expression pattern of Raldh2,
which encodes the major enzyme responsible for pro-
duction of RA in the developing embryo (Niederreither
et al., 1999, 2002; Ross et al., 2000), in wild-type and mu-
tant embryos. In the pharyngeal region of wild-type em-
bryos, Raldh2 expression at E10.5 is restricted to a site
of posterior mesoderm caudal to the pharyngeal arches
(Figure 4O). In Tbx12/2 and Crkl2/2;Tbx12/2 embryos,
dramatic anterior expansion of this expression domain
in the pharyngeal mesoderm was observed, while the
expression pattern of Raldh2 elsewhere in the embryo
was unchanged (Figures 4Q and 4R). Similar changes
in the expression of Raldh2 were observed at E9.5 in
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bryos
(A–D) Rarb expression detected by in situ hy-
bridization in (A) wild-type, (B)Crkl+/2;Tbx1+/2,
(C) Tbx12/2, and (D) Crkl2/2;Tbx12/2 em-
bryos at E10.5. The green and yellow arrows
in (B) and the red arrow in (C) and (D) denote
abnormal anterior limits ofRarb expression in
the pharyngeal endoderm in these mutants.
See text for details.
(E–H) RARE-lacZ expression detected by as-
sessing b-galactosidase activity in (E) wild-
type, (F) Crkl2/2, (G) Tbx12/2, and (H) Crkl2/2;
Tbx12/2 embryos at E10.5. The white arrows
denote the anterior limit of reporter expres-
sion in the pharyngeal endoderm. Note the
endodermal staining in (H) that approaches
the first pharyngeal arch. (F–H) The red ar-
rows indicate ectopic reporter activity in the
head mesoderm.
(I–N) RARE-lacZ expression detected by as-
sessing b-galactosidase activity in (I) wild-
type, (J) Crkl2/2, (D) Tbx12/2, (L and M)
Crkl+/2;Tbx1+/2, and (N) Crkl2/2;Tbx12/2 em-
bryos at E9.0. The position of otic vesicles is
marked by dotted circles. Note that the ante-
rior limit of RARE reporter (red arrows) in the
head mesoderm overlaps with the position
of the otic vesicles in Tbx12/2, Crkl+/2;
Tbx1+/2, and Crkl2/2;Tbx12/2 embryos, sug-
gesting more anterior localization of an RA
gradient compared to wild-type embryos.
(O–R) Raldh2 expression detected by in situ
hybridization in (O) wild-type, (P) Crkl+/2;
Tbx1+/2, (Q) Tbx12/2, and (R) Crkl2/2;Tbx12/2
embryos at E10.5. The red arrow in (P) indi-
cates ectopic anterior expression of Raldh2
nearing pharyngeal pouch 3 and the cardiac
outflow tract in the ventral mesoderm. Com-
pare with the anterior limit of expression in the ventral mesoderm of the wild-type control indicated by the black arrow in (O). The red arrows
in (Q) and (R) indicate dramatic anterior expansion of Raldh2 expression in the pharyngeal mesoderm. The staining in the first pharyngeal
arch in (R) is a reflection of the slightly older stage of this embryo and is not abnormal.
a, pharyngeal arch; ov, otic vesicle; p, pharyngeal pouch.these mutants (data not shown). In Crkl+/2;Tbx1+/2 em-
bryos, subtle ectopic anterior expression of Raldh2 in
the ventral pharyngeal mesoderm was observed at
E10.5 (Figure 4P). We currently cannot distinguish
whether there is an anterior expansion of the Raldh2
expression domain in Crkl+/2;Tbx1+/2 embryos, or
whether, instead, the ectopic expression observed is
secondary to morphological defects in fourth pharyn-
geal arch formation in these mutants. In either case,
we speculate that this ectopic location of a major source
of RA close to the third pharyngeal pouch may disturb
the normal pattern of RA signaling in the pharyngeal re-
gion and have detrimental consequences for the devel-
opment of structures afflicted in DGS that may be sensi-
tive to levels of RA. No differences in Raldh2 expression
in Crkl2/2, Crkl+/2, or Tbx1+/2 embryos were found at
this stage (data not shown).
Next, we examined the expression of Cyp26a1 and
Cyp26b1, genes encoding the two major RA-degrading
enzymes in the pharyngeal region, in mutant embryos
at E9.5 and E10.5. At these stages, Cyp26a1 is ex-
pressed in the head mesoderm dorsal to the first three
pharyngeal arches, in the ectoderm of the first pharyn-
geal arch and in the dorsal ectoderm of the first, second,
and third pharyngeal clefts, and in the tail bud of wild-type embryos (Figures 5A and 5H) (de Roos et al.,
1999). At E9.5, expression of Cyp26a1 was notably re-
duced in the head mesoderm and pharyngeal ectoderm
of Crkl+/2;Tbx1+/2 embryos; however, by E10.5, expres-
sion in these mutants was comparable to wild-type con-
trols (Figures 5D and 5K). Expression of Cyp26a1 was
more dramatically reduced in the pharyngeal region of
Crkl and Tbx1 single homozygous embryos at E9.5 com-
pared to wild-type controls, with persistent, though not
complete, reduction of expression observed in these
mutants at E10.5 (Figures 5E, 5F, 5L, and 5M). InCrkl2/2;
Tbx12/2 embryos at E9.5, no expression of Cyp26a1
was detected in the pharyngeal region, and expression
of Cyp26a1 by E10.5 in these mutants was minimal (Fig-
ures 5G and 5N). Cyp26a1 expression in Tbx1+/2 em-
bryos appeared to be reduced at this stage (Figure 5C),
whereas Crkl+/2 embryos showed no overt change (Fig-
ure 5B). In all mutants, expression of Cyp26a1 in the tail
bud appeared normal.
We similarly found local changes in the expression of
Cyp26b1 in mutant embryos compared to controls. In
wild-type embryos at E9.5,Cyp26b1 expression was de-
tected in the hindbrain and the caudal pharyngeal endo-
derm (Figure 5O). By comparison, expression of
Cyp26b1 in Crkl+/2;Tbx1+/2 embryos appeared normal
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in Mutant Embryos
(A–N) Cyp26a1 expression detected by in situ
hybridization at (A–G) E9.5 and (H–N) E10.5 in
(A and H) wild-type, (B and I)Crkl+/2, (C and J)
Tbx1+/2, (D and K) Crkl+/2;Tbx1+/2, (E and L)
Crkl2/2, (F and M) Tbx12/2, and (G and N)
Crkl2/2;Tbx12/2 embryos. See text for de-
tails.
(O–V) (O–R) Lateral and frontal views of
Cyp26b1 expression detected by in situ hy-
bridization in (O and S) wild-type, (P and T)
Crkl2/2, (Q and U) Tbx12/2, and (R and V)
Crkl2/2;Tbx12/2 embryos at E9.5. The black
arrowheads in (S) and (T) indicate expression
in the endoderm lining pharyngeal arch 3. The
red arrowheads in (P)–(R) and (T)–(V) indicate
ectopic expression in the pharyngeal ecto-
derm. Frontal views were photographed after
removal of the heart. See text for details.
a, pharyngeal arch.at this stage (data not shown). However, in Tbx12/2 em-
bryos, expression of Cyp26b1 in the pharyngeal endo-
derm was reduced (Figure 5Q), while ectopic expression
of this gene in the pharyngeal ectoderm adjacent to the
otic placode was simultaneously observed (Figures 5Q
and 5U). This ectopic expression in the ectoderm was
likewise observed in Crkl2/2;Tbx12/2 embryos at E9.5
(Figures 5R and 5V), and, in these mutants, the loss of
Cyp26b1 in the pharyngeal endoderm was more pro-
nounced (Figure 5V). Ectopic expression of Cyp26b1 in
the pharyngeal ectoderm was also observed in Crkl2/2
embryos (Figures 5P and 5T). Ectopic expression of
Cyp26b1 in the pharyngeal ectoderm persisted in
Tbx12/2 and Crkl2/2;Tbx12/2 embryos at E10.5, and ec-
topic expression in the anterior pharyngeal endoderm
was additionally observed at this stage (data not
shown).
Regulation of the expression of Cyp26 enzymes in-
volves multiple inputs including RA (Loudig et al.,
2000), and exogenous RA treatment has been shown
to locally induce expression of Cyp26a1 or Cyp26b1 in
developing embryos (Reijntjes et al., 2005; Sakai et al.,
2001). We therefore postulate that the ectopic expres-
sion of Cyp26b1 observed in the ectoderm and anteriorpharyngeal endoderm of Tbx12/2 and Crkl2/2;Tbx12/2
embryos, as well as the abnormal pattern of expression
ofCyp26a1 in the head mesoderm, may be due to a neg-
ative feedback mechanism triggered by aberrant RA sig-
naling in these embryos.
Gain of Function in RA Signaling Contributes
to the Pathogenesis of Thymic Defects
in Crkl+/2;Tbx1+/2 Embryos
The analysis of Crkl and Tbx1 single and compound
homozygous mutants that we have described suggests
that there are potential changes in RA homeostasis
and a local increase in RA signaling in the absence of
Crkl and Tbx1. To assess the functional importance of
these findings to the DGS phenotype observed in
Crkl+/2;Tbx1+/2 mutants, we generated Crkl+/2;Tbx1+/2
embryos in which the gene dosage of Raldh2 was re-
duced by half by timed matings between cis-Crkl+/2;
Tbx1+/2 animals and mice bearing a heterozygous null
mutation in Raldh2 (Mic et al., 2002). When examined
between E15.5 and E18.5 by gross dissection, we found
that the penetrance of thymic hypoplasia was sig-
nificantly and dramatically decreased in Crkl+/2;
Tbx1+/2;Raldh2+/2 triple heterozygous compared to
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icant difference in the penetrance of aortic arch defects
between Crkl+/2;Tbx1+/2 double and Crkl+/2;Tbx1+/2;
Raldh2+/2 triple heterozygous embryos was observed
(Table S1). These results clearly substantiate a function-
ally important role for locally aberrant RA signaling in the
pathogenesis of DGS associated with compound het-
erozygous loss of Crkl and Tbx1.
Reduced Dosage of Fgf8 Enhances Key Features
of the DGS Phenotype in Crkl+/2;Tbx1+/2 Mutants
In addition to the key role played by RA, Fgf signaling is
also critical for pharyngeal development. Fgf8 appears
to be important for pharyngeal pouch development,
pharyngeal arch artery formation, and neural crest sur-
vival (Abu-Issa et al., 2002; Frank et al., 2002), and
mice bearing a hypomorphic allele of Fgf8 in trans to
a null Fgf8 allele display features of DGS. Reduced dos-
age of Fgf8 has been shown to increase the penetrance
of aortic arch defects in Tbx1 heterozygotes (Vitelli et al.,
2002), and we have now reported that reduced dosage
of Fgf8 significantly enhances the Crkl mutant pheno-
type as well (see accompanying manuscript, Moon
et al., 2006 [this issue of Developmental Cell]). We there-
fore assessed the effects of reduced gene dosage of
Fgf8 on the penetrance and expressivity of two key fea-
tures of DGS found in Crkl+/2;Tbx1+/2 mutants. When
examined by gross dissection between E15.5 and
E17.5, we found that the incidence and severity of thy-
mic defects was significantly increased in Crkl+/2;
Tbx1+/2;Fgf8+/2 triple heterozygous embryos compared
to Crkl+/2;Tbx1+/2 mutants (Table S2). Bilateral thymic
defects were observed in all Crkl+/2;Tbx1+/2;Fgf8+/2 tri-
ple heterozygous embryos, and the severity of hypopla-
sia and the incidence of thymic lobe aplasia were exac-
erbated in embryos of this genotype. Reduced dosage
of Fgf8 likewise enhanced the severity of aortic arch de-
fects in Crkl+/2;Tbx1+/2mutants. We found that the inci-
dence of defects likely to cause significant postnatal
morbidity or neonatal lethality (IAA-B with or without
a right retroesophageal arch, respectively) was signifi-
Table 3. Reduced Raldh2 Gene Dosage Decreases the






Embryos at E15.5–E17.5 were isolated from timed mating between
cis-Crkl+/2;Tbx1+/2 and Raldh2+/2 parents. The variation of the thy-
mic size (measured in terms of thymic lobe height) in wild-type and
Raldh2+/2 embryos was within 10% from their average, except that
one wild-type embryo had a small thymic lobe that was approxi-
mately 86% of the average. Thymic lobes were scored hypoplastic
if the size was smaller than 90% of the average of the control em-
bryos in the litter. Postanalysis revealed that thymic lobes judged
normal were 0.998 6 0.062 (mean 6 SD) relative to the average thy-
mic size of the control littermates, whereas those judged hypoplas-
tic were 0.778 6 0.084.
a The number of embryos exhibiting thymic hypoplasia.
b Statistically different from the frequency of the Crkl+/2;Tbx1+/2
group (p = 0.0047, Fisher’s exact test).cantly increased in Crkl+/2;Tbx1+/2;Fgf8+/2 triple het-
erozygous compared to Crkl+/2;Tbx1+/2 double hetero-
zygous mutants (Table S2).
Discussion
Dose-Sensitive Interaction of Crkl and Tbx1
Is Required for Development of Structures
Afflicted in DGS
We have shown that Crkl and Tbx1 both play critical,
dose-dependent roles in pharyngeal segmentation and
patterning, and that compound heterozygosity of these
two 22q11 homologs recapitulates key features of DGS
with dramatic penetrance and expressivity. Our findings
suggest that development of the caudal pharyngeal ap-
paratus is particularly sensitive to the reduced dosage
of Crkl and Tbx1, as development of the fourth pharyn-
geal arch and its associated artery is impaired inCrkl+/2;
Tbx1+/2 embryos. Furthermore, in this and the accom-
panying manuscript (Moon et al., 2006) we have linked
developmental defects associated with loss of Crkl
and Tbx1 to two major signaling pathways (RA and
Fgf8) implicated in the pathogenesis of a DGS-like phe-
notype in model organisms. To our knowledge, these
results provide novel insight into the genetic and devel-
opmental mechanisms underlying malformations asso-
ciated with 22q11 deletions in humans.
Since Crkl encodes an SH2-SH3-SH3 adaptor protein
implicated in tyrosine kinase signaling, and Tbx1 enco-
des a transcription factor, the molecular basis for the
synergy observed between these two genes is not obvi-
ous. Likewise, the expression pattern ofCrkl and Tbx1 is
quite different, as Crkl is ubiquitously expressed, while
Tbx1 is more restricted. There is mounting evidence
that the severe defects observed in Tbx1 homozygous
embryos are due to the loss of Tbx1 action in the pharyn-
geal endoderm (Kochilas et al., 2002; Lindsay, 2001;
Merscher et al., 2001; Piotrowski et al., 2003). The ex-
pression pattern of Crkl and Tbx1 overlaps in this tissue;
however, Crkl protein expression is also enriched in neu-
ral crest derivatives such as smooth muscle and cranial
nerves. Future studies will determine the molecular ba-
sis for the observed synergy between Crkl and Tbx1
and whether these two genes act in the same cells or
in different tissues (or both) during pharyngeal develop-
ment and in the pathogenesis of DGS.
Implications for Human Disease: del22q11 Is
a Contiguous Gene Syndrome
Our finding that the mouse homologs of two 22q11
genes, Tbx1 and Crkl, genetically interact in a dosage-
sensitive manner provides compelling evidence that, in
the majority of cases, DGS is a contiguous gene syn-
drome. The dramatic increase in the penetrance and ex-
pressivity of defects caused by compound heterozygos-
ity ofCrkl and Tbx1 is consistent with the finding that the
majority of patients that present with a DGS phenotype
(w90%) harbor a 3 Mb deletion encompassing both
TBX1 and CRKL, while the occurrence of smaller or
atypical deletions is quite low. No data are currently
available regarding the frequency of different 22q11 de-
letions in the general, nonsyndromic population. Our
data suggest that the propensity to develop manifesta-
tions of DGS may be increased when the dosage of
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stances, genetic modifiers or other factors may render
development of the pharyngeal apparatus sensitive to
the reduced dosage of a single 22q11 gene. For in-
stance, our finding that reduced Fgf8 gene dosage en-
hances the DGS-like phenotype of Crkl mutant embryos
and Crkl+/2;Tbx1+/2 compound heterozygotes, in addi-
tion to previous work demonstrating genetic interaction
between Fgf8 and Tbx1 (Vitelli et al., 2002), suggests that
Fgf8 signaling may affect the penetrance and expressiv-
ity of specific features of DGS associated with 22q11 de-
letions, including either CRKL or TBX1 or the common 3
Mb deletion encompassing both of these genes. In addi-
tion, the possibility remains that heterozygous deletion
of other 22q11 loci may generate additional aspects
of DGS, either independently or as modifiers of the
reduced dosage of either or both TBX1 and CRKL
(Merscher et al., 2001; Scambler, 2000).
Loss of Retinoid Homeostasis and Locally Aberrant
RA Signaling in Embryos Lacking Crkl and Tbx1
The importance of RA in patterning the pharyngeal en-
doderm is well documented, as are the teratogenic ef-
fects of RA on development of the pharyngeal apparatus
(reviewed by Mark et al., 2004). Several recent studies
have demonstrated that perturbation of RA signaling
during embryogenesis can lead to a DGS phenotype in
the mouse (Mulder et al., 1998; Niederreither et al.,
2003; Vermot et al., 2003; Wendling et al., 2000). Until
now, however, no study has directly linked defects in
RA signaling to the pathogenesis of DGS associated
with 22q11 deletions.
Our analysis of embryos lackingCrkl and/or Tbx1 indi-
cates that in the absence of these two genes there is
a gain of function in RA signaling specifically in the pha-
ryngeal region. Ectopic anterior expression of the RARE
reporter was observed in Crkl2/2, Tbx12/2, and Crkl2/2;
Tbx12/2 embryos, indicating that higher than normal
levels and an abnormal distribution of RA are present
in the pharyngeal region. In Tbx12/2 and Crkl2/2;
Tbx12/2 embryos, the pharyngeal endoderm is notably
posteriorized, with ectopic anterior expression of multi-
ple RA target genes (including Hoxb1, Hoxb3, Hoxb4,
Hoxd4, and Rarb) observed. The fact that defects asso-
ciated with exogenous RA exposure at earlier stages of
development are not generally observed in embryos
lacking Crkl and/or Tbx1 suggests that the gain of func-
tion in RA signaling in these mutants is not only region-
ally restricted, but is potentially temporally restricted as
well.
The severe defects in pharyngeal segmentation, pat-
terning, and RA distribution observed in Tbx12/2 and
Crkl2/2;Tbx12/2 embryos correlate with dramatic
changes in the expression pattern of Raldh2, Cyp26a1,
and Cyp26b1 in the pharyngeal region in these mutants.
A recent study has also reported quantitative changes in
the levels of Raldh2 and Cyp26a1 expressed in Tbx1+/2;
Df1+/2 compound heterozygous mutants detected by
microarray analysis (Ivins et al., 2005). Changes in the
expression patterns of the RARE reporter or Raldh2,
Cyp26a1, and Cyp26b1 were subtle or undetectable at
all stages in Crkl+/2;Tbx1+/2 embryos compared to
wild-type controls. We speculate that some differences
in the pattern and levels of gene expression and distri-bution of RA in Crkl+/2;Tbx1+/2 embryos may not readily
be detected by the methods we have used in our
analysis. Furthermore, even subtle differences in the
stereotypic pattern of RA signaling may nonetheless
be detrimental to development of caudal pharyngeal
structures, as many of these structures (including the
thymus and parathyroid glands) have been experimen-
tally shown to be sensitive to excess RA (Mulder et al.,
1998). Such speculation is supported by our finding
that the penetrance of thymic hypoplasia is dramatically
reduced in Crkl+/2;Tbx1+/2;Raldh2+/2 triple heterozy-
gous embryos compared to Crkl+/2;Tbx1+/2 mutants.
There are several possible explanations for the find-
ings that thymic defects were not completely sup-
pressed and that the penetrance of aortic arch defects
was not significantly decreased in Crkl+/2;Tbx1+/2 mu-
tants by reducing the dosage of Raldh2. One explana-
tion may be that as there are changes in the expression
of numerous genes involved in RA metabolism (Raldh2,
Cyp26a1, Cyp26b1) and signaling (Rarb) in the absence
of Crkl and Tbx1, reducing the gene dosage of Raldh2
may not completely rescue the gain of function in RA
signaling in Crkl+/2;Tbx1+/2 mutants to wild-type levels.
An alternative, although not exclusive, explanation may
be that aberrant RA signaling may be only one of multi-
ple factors that contribute to the etiology of thymic de-
fects and aortic arch defects in Crkl+/2;Tbx1+/2 em-
bryos. The findings that Fgf8 signaling modifies the
phenotype of Crkl+/2;Tbx1+/2 as well as Crkl+/2 and
Tbx1+/2 mutant embryos (Moon et al., 2006; Vitelli
et al., 2002) support the hypothesis that multiple factors
may contribute to the pathogenesis of defects observed
in Crkl+/2;Tbx1+/2 embryos. It will be informative to de-
termine whether reducing the gene dosage of Raldh2
by half suppresses other aspects of DGS observed in
Crkl+/2;Tbx1+/2 embryos, and whether such a reduction
of Raldh2 dosage more completely rescues the milder
presentation of DGS features observed in Tbx1 single
heterozygous embryos.
Complete loss of Raldh2, Cyp26a1, or Cyp26b1 has
devastating consequences for development of the tis-
sues in which these genes are expressed, suggesting
that levels of RA must be finely tuned at a local level to
ensure proper development, and that Raldh and cyto-
chrome P450 enzymes play a major role in establishing
and maintaining this balance. Tbx1 and Crkl may play
critical, dose-sensitive roles in the temporal and spatial
regulation of RA signaling in the pharyngeal region by di-
rectly or indirectly regulating the level or pattern of ex-
pression of these genes involved in RA metabolism.
We therefore propose that disruption of retinoid homeo-
stasis due to the loss of these genes is an early and im-
portant step in the pathogenesis of DGS in del22q11.
Based on our findings, we also speculate that genes in-
volved in RA metabolism and signaling may act as modi-
fiers of the phenotype associated with 22q11 deletions.
Furthermore, if RA production and signaling is elevated
and/or occurs ectopically and the capacity to degrade
RA is impaired in the absence of Crkl and Tbx1, it is
also possible that levels of maternal RA or retinol expo-
sure that are not normally teratogenic to wild-type em-
bryos may significantly worsen the severity of defects
caused by loss of these genes. Future studies will further
explore the link between levels of RA signaling and the
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lacking Crkl and Tbx1.
Experimental Procedures
Mice
We previously described Tbx1 and Crkl null alleles, Tbx1tm1Pa and
Crkltm1Imo, respectively (abbreviated as Tbx12 and Crkl2) (Guris
et al., 2001; Jerome and Papaioannou, 2001).Tbx1+/2mice (originally
generated with R1 ES cells and maintained by a 129S6/SvEvTac
backcross) have been backcrossed to C57BL/6J or 129S4 inbred
strains. Crkl+/2 mice (originally generated in the 129S4/SvJaeSor in-
bred background) have been maintained by continual C57BL/6J or
129S4 backcross for more than 11 generations. Timed mating be-
tween Tbx1+/2 and Crkl+/2 mice in a partially mixed 129Sv;C57BL/
6 background (N2-N5 toward C57BL/6) was used to obtain trans-
compound heterozygous embryos. As Crkl and Tbx1 are closely
linked on mouse chromosome 16 with a physical distance of w1.1
Mb, compound heterozygosity for Crkl and Tbx1 in cis was gener-
ated as a result of meiotic recombination. Two cis-Crkl+/2;Tbx1+/2
compound heterozygotes out of a total of 106 pups were obtained
by breeding trans-Crkl+/2;Tbx1+/2 compound heterozygotes (in a
129/Sv background) to wild-type C57BL/6 mice, while the remain-
ing pups were heterozygous for either Crkl (50 pups) or Tbx1 (54
pups) (Fisher’s exact test, p < 2.23 10216). A test cross of these com-
pound heterozygotes with C57BL/6J wild-type mice generated 15
wild-type or 10 compound heterozygous mice, but no heterozygotes
were recovered for a single locus, thus confirming that the parent ge-
notype was indeed cis-compound heterozygous (Fisher’s exact test,
p = 3.063 1027). Further backcross with C57BL/6 was carried out to
obtain N3–N5 generations for the current studies. Double homozy-
gous mice were obtained by intercross between cis-compound het-
erozygotes. To monitorRARE activities, genetic crosses were set up
with the RARE-hsp68lacZ strain (Rossant et al., 1991; a gift from
W. Cardoso, originally from J. Rossant). Heterozygosity of this re-
porter was identified by PCR with hsp68F1 (50-agacgcgaaactgctg
gaagatt-30) and lacZR1 (50-gctggcgaaagggggatgtgct-30) primers.
The reporter activity was assessed by using a standard protocol
and the colorimetric substrate Salmon-gal (Biosynth). Crkl+/2;
Tbx1+/2;Raldh2+/2 triple heterozygous embryos were obtained by
timed mating between cis-Crkl+/2;Tbx1+/2 compound heterozy-
gotes in a C57BL/6 background (N3-N5) and Raldh2+/2 heterozy-
gotes in a mixed 129Sv;B6;Black Swiss background (Mic et al.,
2002). Crkl+/2;Tbx1+/2;Fgf8+/2 triple heterozygous embryos were
generated by timed mating between cis-Crkl+/2;Tbx1+/2 compound
heterozygotes in a C57BL/6 background (N3-N5) and Fgf8+/2 heter-
ozygotes in a C57BL/6 background (>N5) (a gift from Anne Moon) or
by timed mating between surviving Crkl+/2;Tbx1+/2;Fgf8+/2 triple
heterozygotes with C57BL/6 wild-type animals.
Intracardiac Ink Injection
The cardiac ventricles of embryos isolated between E10.5 and E11.5
were injected with India ink through a pulled glass capillary as pre-
viously described (Guris et al., 2001; Lindsay et al., 1999). Embryos
were postfixed with 4% paraformaldehyde and preserved in 70%
ethanol.
In Situ RNA Hybridization
Whole-mount in situ RNA hybridization on E9.5 and E10.5 embryos
was performed by using a standard protocol. RNA probes were
made from plasmid templates including the following cDNA inserts:
Pax1, Gcm2, Hoxa2, Hoxa3, Hoxb3, and Hoxd3 (gifts from N. Man-
ley); Hoxd4 (a gift from M. Featherstone); Hoxb1 and Hoxb4 (gifts
from R. Krumlauf); Raldh2 (a gift from P. Dolle); Cyp26a1,
Cyp26b1, and Rarb (mouse cDNA clones from Open Biosystems).
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